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Abstract
The brain is not only a control center of the body but also a part of the way 
that the body can communicate with external environments. The spatial and 
temporal events of brain development are well-defined. These processes are 
sequentially regulated by intrinsic and external factors, such as gene. Disruption 
of these steps results in malformation and malfunction of the brain. Neurotoxin 
may affect our developing nervous system as a kind of endogenous and exog-
enous factor. For classical neurotoxins, such as heavy metals, snake venom, 
and bacterial toxins, the underlying toxin-mediated physiological pathways are 
relatively clear, and their antidotes are usually available. However, for atypical 
neurotoxins, such as air pollutants, food additives, and manufactural com-
pounds, their effects on the nervous system are ordinarily extended and not easy 
to detect. In addition, the corresponding mechanism is too complex to define. A 
single and effective antidote against these atypical neurotoxins is uncommon, 
so prevention is better than cure with this kind of toxin. This chapter starts with 
the introduction of endogenous and exogenous neurotoxins, how they affect 
nervous system and their potential antidotes, followed by the impact of atypi-
cal neurotoxins in fetal brain development and their possible preventative or 
therapeutic methods.
Keywords: environmental or atypical neurotoxins, neurodevelopmental defects, 
neurodegenerative disorders
1. Introduction
Neurotoxins are toxic substances that destroy the nervous system. Depending 
on their origin, it could be divided into endogenous or exogenous neurotoxins. 
Endogenous is the neurotoxin produced by the human body itself, while exog-
enous one comes from the surrounding environment. Neurotoxins can damage 
neurons, nerve fibers, glias, and myelin, causing the atrophy of nerve fibers and 
neurons, or demyelination, which in turn affects neural circuits and functions. 
Ultimately, defect in nerve system affects the physiological homeostasis of human 
body, which results in corresponding signs and symptoms of poisoning. Macro-
manifestations of neurotoxin exposure may associate a wide range of central 
nervous system impairments such as cognitive deficit [1], memory impairment 
[2], epilepsy, and dementia [3, 4].
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2.  Classic neurotoxins and their possible mechanisms of action that 
damage the nervous system
2.1 Exogenous neurotoxin
Exogenous toxins are foreign synthetic by name, and common exogenous 
neurotoxins include metal neurotoxins (e.g., lead), microbial neurotoxins (e.g., 
botulinum), biotoxins (e.g., tetrodotoxin), and chemical toxoids (e.g., ethanol). 
Different types of toxins have their different mechanisms of action in nervous sys-
tem: (1) metal neurotoxins, such as lead and aluminum, usually migrate to the brain 
through the blood circulation by destroying the structure of or inhibition of the 
blood-brain barrier (BBB) [5]. Once it penetrates the BBB and reaches the brain, it 
can cause damage to brain and thus the emergence of diseases such as learning dis-
abilities [6, 7], disorders in motor coordination [8, 9], and Alzheimer's disease [10]. 
At present, these metal neurotoxins are still widely used in food preparation, like 
in the packaging factory. Furthermore, due to the environmental pollution, these 
substances are also widely existing in the food chain [11]. (2) Microbial neurotoxins 
are produced by microorganisms, mostly from bacteria, such as botulinum, tetanus 
toxin, and lipopolysaccharide (LPS). The main mechanism of microbial neurotox-
ins that disturb the nervous system is inhibiting the communication of neurons. 
Microbial neurotoxins prohibit the release of neurotransmitters from synaptic 
vesicle [12, 13], thereby terminating nerve messages, which may lead to a decrease 
in muscle tension [14, 15], muscle atrophy [16], and paralysis [17, 18]. If it affected 
the respiratory muscles, it could cause asphyxiation and death [19, 20]. (3) Bio-
neurotoxins come from organisms that produce these toxins as tetrodotoxin existed 
inside pufferfish's skin and gastrointestinal tract, snake venom produced by snakes, 
and chlorotoxin produced by scorpion. Some of which reduce the permeability of 
the ion channels in neurons and thus decrease neuronal communication. Different 
bio-neurotoxins can target different ion channels. For example, the tetrodotoxin is 
specific to the sodium ion channel [21], while the conotoxin produced by the conch 
is specific to the calcium ion channel [22]. The other bio-neurotoxins may not affect 
ion channel but have impact on neurotransmitter gated channel, like bungarotoxin, 
a type of snake venom [23]. (4) Chemical neurotoxins are a class of toxins with a 
broader mechanism of action. For example, ethanol has been shown to induce ner-
vous system damage and affect the body in various ways: studies show that ethanol 
can alter the composition of nerve cell membranes [24], inhibiting the activation of 
NMDA receptors [25], causing the imbalance of cellular calcium ion concentration 
[26], facilitating the mitochondrial dysfunction [27], and increasing the oxidative 
stress inside the neurons [28], and that destroy the nervous system, leading to brain 
atrophy, encephalitis, neurodegeneration, cognitive decline, developmental disor-
ders, and other neurological diseases [29, 30].
2.2 Endogenous neurotoxins
Endogenous neurotoxins, such as nitric oxide and glutamate, originate in the 
body and usually have their typical physiological role and function in the body. 
When the concentration of these endogenous compounds becomes higher, it can 
lead to dangerous effects: (1) glutamate is the primary neurotransmitter of the 
nervous system, accomplishing the chemical transmission in synapses. The normal 
concentration of glutamate is responsible for the regular performance of neurons. 
One of the most critical uses in nervous system is an excitatory neurotransmit-
ter, which is related to the long-term potentiation in memory and learning. 
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High concentrations of glutamate become toxic to the neurons by increasing the 
permeability of calcium ions. It leads to an increase in cellular calcium concentra-
tion, then over-activates the calcium-associated enzymes, and eventually results 
in neuronal swelling and cellular death. This phenomenon is known as excitotox-
icity. Studies have linked this mechanism to many neurological disorders, such 
as Huntington's disease, epilepsy, and stroke [31, 32]. (2) Nitric oxide (NO) is a 
secondary messenger synthesized by neural nitric oxide and commonly used in 
neurons. It regulates synaptic plasticity of the nervous system, smooth muscle 
relaxation in nerve and vascular system, and neurovascular dilation [33, 34]. 
Abnormal concentration of NO is associated with asthma, schizophrenia, and 
Huntington’s disease [35–37]. The neurotoxicity of NO is based on glutamate-
induced excitotoxicity. NO is response to glutamate-mediated NMDA activation, 
which is produced by calcium-dependent signaling. An elevated rate of glutamate 
excitotoxicity could lead to an increase in neuronal NO level. Over-dose of NO can 
also increase oxidative stress, which further induces DNA damage and apoptosis 
[38]. Therefore, an abnormal level of NO inside the nervous system can produce 
significant neuronal toxic effects.
3. Common antidotes
Common antidotes, such as antioxidants and antitoxins, can effectively reduce 
nerve damage induced by neurotoxins: (1) Antitoxin or antiserum is an antidote 
that uses antibodies to neutralize specific action of the toxins. Antitoxin is produced 
by individual animals, plants, or bacteria that are responded to toxin exposure. 
Antitoxins are made in organisms and can be injected into other organisms, 
including humans. Its most common use in the human body is antivenom [39]. (2) 
Antioxidants are compounds that inhibit oxidative stress, such as glutathione or 
ascorbic acid (vitamin C). If neurotoxins cause oxidative stress, antioxidants can be 
used to reduce the toxic reactions and side effects [40, 41].
4. Neurotoxins and the developing nervous system
4.1 Brain development
Brain is the computational core of our nervous system and is a place where 
animals can process and coherent the stimulus gathering from outside or internal 
surroundings and then sending out the response. It is responsible for many higher-
order functions such as coordination of movement, learning and memory, and 
language and speech. Therefore, a well and the fully developed brain is essential to 
regulate these functions. Many intrinsic and external factors are required for brain 
development. Intrinsic factors are like hormones or regular development-associated 
gene expression, and external factors are like essential nutrients. Abnormal impact 
on these factors results in brain malformation and malfunction. For example, 
abnormal expression of thyroid hormone affects cerebellar development, motor 
performance, and severe anxiety [42, 43]; dysfunction of cyclin-dependent kinase 
5 and insulin-like growth factor-I results in neurological disorders and neurode-
generative diseases [44, 45]; iron deficiency in early life causes irreversible effect 
on behavioral and neural development [43, 46]; and (n-3) fatty acid plays a role in 




4.2 General events during the timeline of fetal brain development
During cerebral development, brain cells go through the process that includes 
replication and migration. The replication of the brain cells is also called neuro-
genesis, which starts from the 8th week of gestation in humans and the 10th day 
in rodents [48]. Neurogenesis is the formation of neurons from neural stem cells 
near the area of lateral ventricles occurring during embryonic development and is 
responsible for producing all the various types of neurons of the brain. Neuronal 
migration mainly happens between the 12th and 24th week of gestation in humans 
and the 11th and 16th day in rodents [49, 50]. Neurons pass the subplate and migrate 
into the cortical plate along the radial glial process starting from the subventricular 
zone with an inside out pattern that forms six-layered neocortical laminae [51], also 
known as cortex. We may look at these processes in detail through rodent studies: 
neuronal progenitor cells (NPCs) form the earliest cortical neurons and lie inside 
the preplate on the 10.5th day of pregnancy, which is divided into the superficial 
marginal zone, the cortical plate, and the subplate. The radial glial cells (RGCs) are 
also generated from NPCs at around 11th to 12th day of gestation, which owns the 
unique morphology with their soma inside the ventricular zone, their short pro-
cesses extending the apical side of ventricle, and their long processes elongating to 
basal lamina. Newly formed neurons use the processes of RGCs as guiding railroad 
to migrate from the ventricular zone toward their final destination inside the corti-
cal plate. Early-born neurons give rise to layers I, V, and VI, and later-born neurons 
migrate from past layers V and VI to the other layers (layers II to IV) of the cortical 
plate [52]. This is also known as in-side-out migration.
Different cortical layers have different functions; for example, the neurons of 
the 6th layer remarkably express the T-box brain 1 (Tbr1) protein, which regulates 
cell migration and differentiation during embryonic development [53–55], and 
also is responsible for the connection between cortex and thalamus in the devel-
oped brain [56]. The cortical neurons of the 5th layer mainly express COUP-TF-
interacting protein 2 (Ctip2; also known as Bcl11b), a C2H2 zinc finger transcription 
factor, and link the cortex with brain stem and spinal cord [57]. Special AT-rich 
sequence-binding protein 2 (SATB2) also known as DNA-binding protein SATB2 
is highly expressed in the neurons with layers II and III, which is associated with 
neuronal morphogenesis [58]. In adult brain, the neurons in layers II and III medi-
ate communication across cortical regions and with the amygdala [59, 60].
After the nerve cells migrate to the destination, they begin to develop neurites 
in order to form synapses, which communicate with other brain cells. Neurites 
are composed of axons and dendrites. Axons transmit messages, and dendrites 
receive them. Both of which shape neural circuits. Most of the topics discussed are 
dendritic patterns. Dendrites are highly branched bush-like cellular extensions that 
mediate the enormous majority of presynaptic and environmental inputs, which 
regulate neuronal communication. Dendritic patterning is critical for proper neuro-
nal function and has served as the basis for the classification of neuronal subtypes 
[61, 62]. The development of dendrite is a complicated multistep process. First, 
neurites initiate and form a structure called lamellipodia. Axons outgrow from 
minor processes followed by the outgrowth of dendrites. Dendrites then start to 
branch and form dendritic spines. After the process of pruning, dendritic branches 
are fully matured, and synapses are formed [62–64]. These steps are regulated by 
intrinsic genetic signals and extracellular cues [64]. Disruption of these pathways 
results in abnormal development in dendrite patterning that sequentially affects 
communication between neurons, which further leads to disruption of neuronal 
circuitry, and finally, whole nervous system breaks down. For example, mutation in 
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the human neural cell adhesion molecule L1 and Neuro-p24, a membranous protein, 
affects neurites’ outgrowth and extension [65, 66]. Many well-known neurodegen-
erative diseases, such as Rett syndrome (RS) and autism, are genetic defects with 
well-defined anomalies in dendritic patterning [67, 68]. Hence, the integrity of 
dendrite morphology is crucial for maintaining normal function of brain circuitry 
and neuronal networks.
4.3 Genetic factors affect brain development
Gene is the main intrinsic factor that affects brain development, which con-
tained highly programmed information related to neurogenesis and migration. 
These genetic factors include integration of reelin, Lis-1, and doublecortin [50, 69, 
70]. The most studied genes are those encoding the dopamine inactivator catechol-
O-methyl transferase (COMT), neurotrophin, brain-derived neurotrophic factor 
(BDNF), the schizophrenia candidate gene neuregulin (NRG1), and the serotonin 
transporter (5-HTT), for example, take neurotrophins. Neurotrophins play an 
essential role in mediating neuronal survival and brain development. There are 
four types of neurotrophins: neuronal growth factor [71], brain-derived neuro-
trophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5). 
In their mature forms, these neurotrophins can bind as homodimers to specific 
tropomycin-related kinase (Trk) receptors. TrkA binds to NGF, TrkB binds to 
BDNF and NT-4/5, and TrkC binds to NT-3. Trk receptors are part of a group of 
receptor tyrosine kinases. Ligand binding results in dimerization of the receptor. 
The dimerized receptors phosphorylate several conserved tyrosine residues on 
one another [72–74]. This allows for proteins containing phosphotyrosine bind-
ing (PTB) or Src homology (SH2) domains to dock, and this docking activates 
intracellular signaling cascades that include Ras-Raf-Erk, PI3 kinase-Akt, PLC-
γ-Ca2+, NF-κB, and some protein kinase C pathways [73]. Neurotrophins exist 
in two states: proteolytically processed, which is the mature form and can bind 
the various Trk receptors, or unprocessed, which allows them to bind with high 
affinity to p75 neurotrophin receptor (NTR). Processed neurotrophins can still 
bind to p75NTR but with much lower affinity than to the Trk receptors. Binding of 
processed or unprocessed neurotrophins to p75 may elicit several responses includ-
ing cell death [72, 73]. Recent studies also show that extracellular stimuli (NGF, 
BDNF, and epidermal growth factor) induced Rac activity, which is involved in 
neurotrophin-derived signaling and neuronal migration [75]. Deficiency in these 
intrinsic regulators disrupts neuronal migration and cortical laminar organization 
[76, 77], causing morphological abnormalities, such as schizencephaly, poren-
cephaly, lissencephaly, macrogyria, and microgyria [78]. These lead to psychiatric 
and neurological disorders [69, 79, 80].
4.4 Examples of common neurotoxins on fetal brain development
The blood-brain barrier (BBB) is a crucial example of protection against toxins 
and other adverse compounds reaching the brain. BBB of the developing brain is not 
fully formed at the beginning of gestation, and therefore, fetal will be more vulner-
able to the neurotoxins [81, 82]. For example, long-term exposure to nicotine during 
pregnancy directly affects acetylcholine systems and brain cell replication and 
differentiation, which consequently results in behavioral deficits of the offspring 
[83, 84]; prenatal, postnatal, and adolescent administration of alcohol affects gene 
expression (e.g. c-fos), causes abnormalities of brain structure and function, and 
finally disrupts brain development permanently and irreversibly [85, 86].
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4.5 The impact of atypical neurotoxins on the developing brain
In the current industrialized society, atypical neurotoxins may also have hid-
den influence on normal brain development. The impacts of these agents on the 
processes of brain development are diverse and the productive time extends from 
prenatal to adolescent period [85]. Prenatal exposure to carbofuran, a carbamate 
pesticide, decreases nestin expression, histone-H3 phosphorylation, and the 
number of glial fibrillary acidic protein and SOX-2 co-labeled cells, which further 
leads to neurodegeneration and cognitive deficits in offspring [87]; Maternal 
application of dicholoacetonitrile (a disinfectant in our drinking water), benzyl 
benzoate (a antiparasitic insecticide), and trimethyltin (a stabilizer for plastics 
in paints) may induce oxidative stress and then result in neurodegeneration in 
fetal brain [88–90]; maternal infection is associated with the increased levels 
of proinflammatory cytokines in the amniotic fluid [91], umbilical cord plasma 
[92], and cerebral palsy [93, 94] as well as neurodevelopmental disorders such as 
schizophrenia [95] and autism spectrum disorders [96]. The findings in experi-
mental models of maternal infection manifest the role of inflammatory response 
in the alteration of fetal neuronal morphology [97], astrocytosis, ventriculo-
megaly, changes in oligodendrocyte precursors [98], reduction of oligodendrocyte 
number, hypomyelination of brain [99] and a decrease of dopaminergic and 
serotoninergic neurons in the offspring [100], all of which are capable of leading 
to brain formative deficits. Indeed, maternal infection induces changes in brain 
developmental events, including neurogenesis, myelination, synaptogenesis as 
well as cell migration [101, 102]. Neuroinflammation has been reported to be 
highly associated with numbers of neurological and pathological diseases, such as 
cerebral palsy [94], schizophrenia [95], and autism spectrum disorders [96].
However, the precise molecular mechanisms of these exogenous agents that 
cause abnormal brain development largely remain unknown. Moreover, there 
are other possible harmful candidates needed to reveal. For example, monocyclic 
aromatic amines (MAAs) are a group of chemicals ubiquitously present in the 
environment. Exposure assessments indicate that most individuals experience 
lifelong exposure to these compounds from several sources, such as occupational 
exposure via tobacco smoke, herbicides, or hair dye, which are considerable in 
causing bladder cancer [103]. In vivo evidence has demonstrated the carcinogenic 
potential of most alkyl aniline compounds. For examples, 2,6-dimethylaniline 
(DMA) is responsible for nasal carcinogenesis [104]; Gan and colleagues indicated 
that 2,6-DMA, 3,5-dimethylaniline (3,5-DMA), and 3-ethylaniline (3-EA) are 
strongly associated with bladder cancers [105]. Currently, only 2,6-DMA is cat-
egorized as a possible human carcinogen by IARC [106]. However, the threats of 
other alkyl anilines cannot be neglected that 2,6-DMA, 3,5-DMA, and 3-EA can be 
metabolized as electrophilic intermediates, which further bind to DNA and form 
adducts. Skipper and colleagues report that three alkyl anilines can be metabolized 
as electrophilic intermediates and induce the production of DNA adducts, followed 
by attacking their putative targets, like bladder. Moreover, their results indicated 
that the adduct levels were the highest in animals given 3,5-DMA and the lowest 
in that given 3-EA. Furthermore, 3,5-DMA has been indicated not only to play a 
significant role in the etiology of bladder cancer in humans but study using in vivo 
experiments also strongly suggested that DNA adducts formed by 3,5-DMA might 
account for its presumptive activity [107]. A recent study additionally proves that 
2,6-DMA and 3,5-DMA cause a single base-pair transition in the guanine-hypoxan-
thine phosphoribosyltransferase (gpt) gene in an in vitro model [108]. MMAs are 
activated through cytochrome P450-catalyzed oxidation of the amino group, fol-
lowed by extensive esterification of N-hydroxylamine and heterolysis of the N▬O 
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bond to produce a reactive nitrenium ion. The ion then interacts with DNA base 
and forms covalent adducts [108, 109]. Furthermore, the other major product of 
hydroxylation, aminophenol, also has the ability to damage DNA by electrophilic 
attack at nucleophilic DNA bases that lead to mutagenesis and carcinogenesis. 
Aminophenol becomes electrophilic upon 2-electron oxidation to quinine imines, 
followed by Michael addition reactions as well as nucleophilic addition at the keto 
and imino carbon centers. Finally, DNA adducts are formed [103, 110]. Moreover, 
quinines react directly with proteins through thiol addition. Thioether addition 
products are responsible for the production of reactive oxygen species (ROS) 
[111, 112]. Accordingly, oxidation of alkyl anilines is generally regarded as a critical 
bioactivation. Indeed, studies have shown that the major metabolite of 3,5-DMA 
and 3,5-dimethylaminophenol (3,5-DMAP) is responsible for the ROS production, 
which contributes to the apoptotic cytotoxicity in mammalian cell lines [113, 114]. 
Furthermore, a recent in vivo study has shown that 3,5-DMA-induced ROS produc-
tion disrupts the dendrites patterning of the cortical cells and causes the abnormal 
cortical layer distribution in developing fetal brain [115].
The most popular topic of air pollution, fine particular matter such as PM2.5, has 
been reported to have massive impact on neurodevelopment. A study displays that 
PM2.5 can enter the maternal amniotic fluid system by inhalation and directly causes 
the delay in brain development of the fetal rat. Besides, microarray data demonstrated 
that PM2.5 mainly increases the risk of neurological diseases in the offspring, such as 
Alzheimer’s disease, epilepsy, autism, learning and memory disorders, and emotional 
control disorders [116]. Up-to-date study shows that PM2.5 increases the number of 
white blood cell, upregulates the inflammatory response, induces the memory impair-
ment, and declines in dendritic branches of the hippocampi of the offspring [117].
5. Discussion and conclusion
The human brain is the most complex system in biology, and its function depends 
on the various connections of nerve cells or the interaction between brain regions. 
Besides, there is growing evidence that many mental and neurological disorders are 
associated with neurodevelopmental abnormalities, which, according to epidemio-
logical statistics, include autism, attention deficit hyperactivity disorder, dyslexia, 
and other cognitive impairments affecting millions of children worldwide [118, 119]. 
During the fetal and infant periods, they are most susceptible to environmental 
neurotoxin, which can cause permanent brain damage during these sensitive develop-
mental stages [82]. Classical neurotoxins, such as heavy metal neurotoxins, microbial 
neurotoxins, bio-neurotoxins, and chemical neurotoxins, are mentioned earlier in this 
chapter. As for atypical neurotoxins, such as 3,5-DMA mentioned in the previous sec-
tion, their effects are not immediate and not apparent, so their damage to the nervous 
system is not easy to detect. Instead, once it is detected, the damage is already severe 
and irreversible, such as neurodegeneration or developmental disorders [120, 121]. 
Some of these atypical neurotoxins are hidden in the surrounding environment, and 
some are obvious but neglected because of slow action, such as air pollution. Because 
there is no immediate risk, it is often ignored in clinical or in research. Therefore, how 
to find an efficient antidote or effective daily health care methods against this neuro-
toxin, especially in current aging society, become much more critical.
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